Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and tolerability of
sequential use of vinorelbine and capecitabine as first line therapy in patients with MBC.